Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced it will ...
GEN

Benefits of PCR-Based Molecular Diagnostics

In vitro diagnostics (IVD) is an umbrella term for tests conducted on blood or tissue samples to detect diseases, determine the efficacy of novel or established treatments, and monitor health.

Seegene Unveils STAgora and CURECA at ESCMID Global 2026

Seegene, a global total solution provider for molecular diagnostics, announced on April 20 that it participated in the ESCMID Global 2026·ESCMID ...